These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9142776)

  • 21. Primary cytomegalovirus infection in liver transplant recipients: comparison of infections transmitted via donor organs and via transfusions. Boston Center for Liver Transplantation CMVIG Study Group.
    Falagas ME; Snydman DR; Ruthazer R; Griffith J; Werner BG
    Clin Infect Dis; 1996 Aug; 23(2):292-7. PubMed ID: 8842266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytomegalovirus, human herpesvirus-6, and human herpesvirus-7 in adult liver transplant recipients: diagnosis based on antigenemia.
    Sampaio AM; Thomasini RL; Guardia AC; Stucchi RS; Rossi CL; Costa SC; Boin IF
    Transplant Proc; 2011 May; 43(4):1357-9. PubMed ID: 21620128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of cytomegalovirus DNA by a fully automated real-time PCR for early diagnosis and monitoring of active viral infection in solid organ transplant recipients.
    Boaretti M; Sorrentino A; Zantedeschi C; Forni A; Boschiero L; Fontana R
    J Clin Virol; 2013 Feb; 56(2):124-8. PubMed ID: 23182772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of cytomegalovirus infection with human leukocyte antigen genotypes in recipients after allogeneic liver transplantation.
    Fan J; Meng XQ; Yang MF; Zhou L; Chen XM; Hu MJ; Fan WW; Ma WH; Li LJ
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):34-8. PubMed ID: 16481279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigenemia in the diagnosis and monitoring of active cytomegalovirus infection after liver transplantation.
    van den Berg AP; Klompmaker IJ; Haagsma EB; Scholten-Sampson A; Bijleveld CM; Schirm J; van der Giessen M; Slooff MJ; The TH
    J Infect Dis; 1991 Aug; 164(2):265-70. PubMed ID: 1649873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Detection of cytomegalovirus in urine specimens from renal transplant recipients using polymerase chain reaction].
    Takamiya H; Wada C; Ohtani H
    Rinsho Byori; 1992 Jan; 40(1):61-6. PubMed ID: 1312182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors of cytomegalovirus infection after pediatric liver transplantation.
    Kawano Y; Mizuta K; Sanada Y; Urahashi T; Ihara Y; Okada N; Yamada N; Sasanuma H; Sakuma Y; Taniai N; Yoshida H; Kawarasaki H; Yasuda Y; Uchida E
    Transplant Proc; 2014 Dec; 46(10):3543-7. PubMed ID: 25498086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value.
    Martín-Dávila P; Fortún J; Gutiérrez C; Martí-Belda P; Candelas A; Honrubia A; Barcena R; Martínez A; Puente A; de Vicente E; Moreno S
    J Clin Virol; 2005 Jun; 33(2):138-44. PubMed ID: 15911429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitation of cytomegalovirus DNA by the polymerase chain reaction as a predictor of disease in solid organ transplantation.
    Ghisetti V; Barbui A; Franchello A; Varetto S; Pittaluga F; Bobbio M; Salizzoni M; Marchiaro G
    J Med Virol; 2004 Jun; 73(2):223-9. PubMed ID: 15122796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitivity of blood and tissue diagnostics for gastrointestinal cytomegalovirus disease in solid organ transplant recipients.
    Fisher CE; Alexander J; Bhattacharya R; Rakita RM; Kirby KA; Boeckh M; Limaye AP
    Transpl Infect Dis; 2016 Jun; 18(3):372-80. PubMed ID: 27004439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytomegalovirus monitoring by polymerase chain reaction of whole blood samples from patients undergoing autologous bone marrow or peripheral blood progenitor cell transplantation.
    Hebart H; Schröder A; Löffler J; Klingebiel T; Martin H; Wassmann B; Gerneth F; Rabenau H; Jahn G; Kanz L; Müller CA; Einsele H
    J Infect Dis; 1997 Jun; 175(6):1490-3. PubMed ID: 9180191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active CMV infection before lung transplantation: risk factors and clinical implications.
    Milstone AP; Brumble LM; Loyd JE; Ely EW; Roberts JR; Pierson RN; Dummer JS
    J Heart Lung Transplant; 2000 Aug; 19(8):744-50. PubMed ID: 10967267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of CMV-DNA in peripheral blood leukocytes of liver transplant patients after ganciclovir treatment.
    Loginov R; Höckerstedt K; Lautenschlager I
    Arch Virol; 2003 Jul; 148(7):1269-74. PubMed ID: 12827460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation.
    Solano C; Muñoz I; Gutiérrez A; Farga A; Prósper F; García-Conde J; Navarro D; Gimeno C
    J Clin Microbiol; 2001 Nov; 39(11):3938-41. PubMed ID: 11682510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance and risk factors of untreated cytomegalovirus viremia in liver transplant recipients.
    Badley AD; Patel R; Portela DF; Harmsen WS; Smith TF; Ilstrup DM; Steers JL; Wiesner RH; Paya CV
    J Infect Dis; 1996 Feb; 173(2):446-9. PubMed ID: 8568308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of real-time polymerase chain reaction and antigenemia assay to detect cytomegalovirus in pediatric transplants].
    Farfán U MJ; Torres T JP; Vergara A A; Donoso W G; Alba G A; Paris D C; Santolaya De P ME
    Rev Chilena Infectol; 2011 Apr; 28(2):113-7. PubMed ID: 21720689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylaxis versus preemptive therapy for cytomegalovirus disease in high-risk liver transplant recipients.
    Bodro M; Sabé N; Lladó L; Baliellas C; Niubó J; Castellote J; Fabregat J; Rafecas A; Carratalà J
    Liver Transpl; 2012 Sep; 18(9):1093-9. PubMed ID: 22532316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The polymerase chain reaction, a sensitive and rapid technique for detecting cytomegalovirus infection after renal transplantation.
    van Dorp WT; Vlieger A; Jiwa NM; van Es LA; van der Ploeg M; van Saase JL; van der Woude FJ
    Transplantation; 1992 Oct; 54(4):661-4. PubMed ID: 1329283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Usefulness of urine and blood cultures for diagnosing cytomegalovirus infection in the kidney transplant recipient].
    Reina Prieto J; Bestard Palmer X; Saurina Gomila J; Gascó Company J; Fernández-Baca Gutiérrez del Alamo V; Munar Roca M
    Rev Clin Esp; 1998 Jan; 198(1):3-6. PubMed ID: 9534340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time to detection of cytomegalovirus (CMV) DNA in blood leukocytes is a predictor for the development of CMV disease in CMV-seronegative recipients of allografts from CMV-seropositive donors following liver transplantation.
    Manez R; Kusne S; Rinaldo C; Aguado JM; St George K; Grossi P; Frye B; Fung JJ; Ehrlich GD
    J Infect Dis; 1996 May; 173(5):1072-6. PubMed ID: 8627056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.